MFS
FBIO icon

Mirabella Financial Services’s Fortress Biotech FBIO Stock Holding History

Mirabella Financial Services’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,053
Closed -$42K – 547
2022
Q1 		$42K Buy
+2,053
New +$56.2K ﹤0.01% 493

Other funds holding FBIO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
CL
CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Mirabella Financial Services's FBIO Position: Q2 2022 in Review

Mirabella Financial Services sold out of Fortress Biotech (FBIO) in Q2 2022, closing a stake of 2,053 shares — an estimated $42K sold.

Mirabella Financial Services first reported a position in FBIO in Q1 2022 and held it in 1 quarter. The position peaked at $42K in Q1 2022. 66 funds tracked by Wall St. Rank hold FBIO as of Q2 2022.

  • Mirabella Financial Services reported no remaining Fortress Biotech position as of Q2 2022 after selling out during the quarter.
  • Mirabella Financial Services sold 2,053 Fortress Biotech shares in Q2 2022, an estimated $42K.
  • Mirabella Financial Services first reported a position in Fortress Biotech in Q1 2022 and held it in 1 quarter.
  • Mirabella Financial Services's Fortress Biotech position peaked at $42K in Q1 2022.
  • 66 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2022.

Based on Mirabella Financial Services's 13F filing for Q2 2022, filed 12 Aug 2022.